| Година | Наслов | Аутор(и) | Тип резултата | Мп-кат. |
| 2022 | Early response to leukocyte interleukin Injection (LI) immunotherapy extends overall survival (OS) in locally advanced primary squamous cell carcinoma of the head & neck (SCCHN): The IT-MATTERS study | Lavin, Philip T; Talor, Eyal; Markovic, D; Cipriano, J | Конференцијски рад | |
| 2022 | Histopathology (HP) biomarkers confirm leukocyte interleukin injection (LI) treatment (Tx) outcome in naive locally advanced primary head & neck squamous cell carcinoma (SCCHN) the IT-MATTERS study | Timar, J; Talor, Eyal; Lavin, Philip T; Ladanyi, A; Kenessey, I; Kiss, A; Markovic, D; Cipriano, J | Конференцијски рад | |
| 2022 | Leukocyte interleukin injection (LI) immunotherapy extends overall survival (OS) in treatment-naive low-risk (LR) locally advanced primary squamous cell carcinoma of the head and neck: The IT-MATTERS study. | Talor, Eyal; Markovic, Dusan; ...; Stosic, Srboljub M; ...; (broj, koautora 20) | Конференцијски рад | |
| 2022 | Novel algorithm for assigning risk/disease-directed treatment (DDT) choice in locally advanced primary squamous cell carcinoma head and neck (SCCHN): Using pretreatment data only. | Talor, Eyal; Lavin, Philip T; Markovic, Dusan | Конференцијски рад | |
| 2023 | Tumor node stage shift following leukocyte interleukin injection neoadjuvant extends overall survival in treatmentnaive locally advanced oral cavity/soft palate squamous cell carcinoma | Timar, J; Lavin, P; Cipriano, J; Markovic, D; Talor, Eyal | Конференцијски рад | |